Clinical Trials
2 trialsNCT00686725 2017-06-14
Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT02343081 2015-04-02
Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System
Monte Verde SA
Phase 4 Completed